BMY vs FIGR · P/E 17, rev $24.46B vs P/E 36, rev $506.9M
Bristol-Myers Squibb Company (BMY) versus Figure Technology Solutions, Inc. Class A Common Stock (FIGR) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Christopher S. Boerner Ph.D..
Figure Technology Solutions, Inc. Class A Common Stock (FIGR) is a capital markets company listed on NASDAQ.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported FIGR revenue for 2025-12-31 was $506.9M. Net income was $133.9M. Revenue was up 48.7% from 2024-12-31 to 2025-12-31. FIGR currently screens at market cap $6.61B and trailing P/E 36.5.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. FIGR currently screens at market cap $6.61B and trailing P/E 36.5.
Not investment advice. Open the BMY and FIGR stock pages for the full models.
Not investment advice.